We share stage and therapeutic area publicly; detailed data available under NDA.
Status: post‑Lead Optimization, preparing for Preclinical Candidate (PCC) nomination. Details available under NDA.
Status: post‑Hit Identification, advancing into Lead Optimization. Lead indication prioritized; specifics under NDA.